Principal Scientist
Genentech, Inc.
South San Francisco, California
Dr Tahnee Dening, PhD, is a Principal Scientist in the Discovery Pharmaceutics group within the Synthetic Molecule Pharmaceutical Sciences Department at Genentech in South San Francisco. She received her PhD from the University of South Australia and completed postdoctoral training at the University of Kansas, prior to joining Genentech. Her research currently focuses on enabling formulations for challenging molecules and novel modalities, such as peptides, as well as characterizing and understanding peptide behavior in the gastrointestinal environment.
Disclosure information not submitted.
What Does “Biorelevant” Mean for Oral Peptides?
Wednesday, May 15, 2024
3:00 PM – 3:15 PM PT